Press release
Radiopharmaceutical Theranostics Market Outlook 2031: From US$ 3.0 Billion in 2022 to Over US$ 12.4 Billion by 2031, Driven by Advances in Cancer Care and Precision Medicine
Radiopharmaceutical Theranostics Market
Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=82604
Market Overview
The Radiopharmaceutical Theranostics Market includes radiopharmaceuticals like Lutetium-177 and Gallium-68 for diagnostic imaging and targeted therapy, primarily in oncology. Valued at US$ 3.0 billion in 2022, the market is expected to reach over US$ 12.4 billion by 2031, driven by a CAGR of 15.1%. It is segmented by radioisotope (Lutetium-177, Gallium-68, Iodine-131, others), application (oncology, cardiology, others), end-user (hospitals, diagnostic centers, research institutes), distribution channel (hospital pharmacies, specialized distributors), and region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa). Oncology dominates due to high cancer incidence, while hospitals lead as end-users.
Key Drivers of Growth
Several factors are propelling the growth of the Radiopharmaceutical Theranostics Market:
Rising Cancer Prevalence: Increasing global cancer cases, with over 19 million new diagnoses in 2020, drive demand for targeted theranostic treatments.
Advancements in Nuclear Medicine: Innovations in radioisotopes and imaging technologies, like PET/CT, enhance diagnostic accuracy and therapeutic efficacy, boosting market adoption.
Adoption of Precision Medicine: Theranostics' ability to personalize cancer treatment aligns with growing demand for tailored therapies, supporting market growth.
Supportive Regulatory Approvals: Fast-track designations for radiopharmaceuticals like Lutathera and Pluvicto by the FDA and EMA accelerate market entry.
Increasing R&D Investments: Significant funding for radiopharmaceutical development, particularly for prostate and neuroendocrine cancers, fuels market expansion.
Top Companies:
Advanced Accelerator Applications (Novartis AG)
Aurobindo Pharma
Bayer AG
Blue Earth Diagnostics (Bracco)
Cardinal Health
Clarity Pharmaceuticals
GE Healthcare
Jubliant Radiopharma
Lantheus Medical Imaging
Navidea Biopharmaceuticals, Inc.
SOFIE
Telix Pharmeceuticals
Visit our report to discover essential insights and analysis - https://www.transparencymarketresearch.com/radiopharmaceutical-theranostics-market.html
Challenges and Barriers
Despite its growth potential, the market faces several challenges:
High Treatment Costs: Radiopharmaceutical therapies are expensive, often costing tens of thousands per dose, limiting accessibility in low-income regions.
Regulatory Complexities: Stringent regulations for radioactive materials and theranostic drugs increase compliance costs and delay approvals.
Limited Infrastructure in Developing Regions: Inadequate nuclear medicine facilities in Africa and parts of Asia-Pacific restrict market penetration.
Short Half-Life of Radioisotopes: The short shelf-life of isotopes like Gallium-68 complicates logistics and distribution, impacting scalability.
Safety Concerns: Radiation exposure risks for patients and healthcare workers require stringent safety protocols, potentially slowing adoption.
Regional Insights
The Radiopharmaceutical Theranostics Market exhibits distinct regional dynamics:
North America: North America dominates, driven by advanced nuclear medicine infrastructure, high cancer prevalence, and robust R&D. The U.S. leads due to early adoption of therapies like Lutathera.
Europe: Europe is a key market, with Germany, France, and the UK benefiting from strong healthcare systems and increasing theranostic approvals.
Asia-Pacific: Asia-Pacific is expected to witness rapid growth, fueled by rising cancer rates, improving nuclear medicine facilities, and investments in China, Japan, and India.
Latin America: Latin America shows moderate growth, with Brazil and Mexico leading due to expanding healthcare infrastructure. Limited facilities slow progress.
Middle East & Africa: This region has the smallest share due to limited nuclear medicine infrastructure. Growth opportunities exist in Gulf countries with rising investments.
Future Opportunities
The Radiopharmaceutical Theranostics Market offers several avenues for growth and innovation:
Novel Radioisotopes: Developing new isotopes with longer half-lives or enhanced targeting could improve efficacy and logistics, driving demand.
Expansion in Emerging Markets: Increasing nuclear medicine investments in Asia-Pacific and Latin America present opportunities for market penetration.
Combination Therapies: Integrating theranostics with immunotherapies or chemotherapies could enhance treatment outcomes and market growth.
AI and Imaging Integration: Leveraging AI for improved diagnostic imaging and treatment planning could boost theranostic adoption.
Collaborations with Pharma Companies: Partnerships between radiopharmaceutical developers and oncology firms can accelerate innovation and market reach.
Browse More Trending Research Reports:
Liquid Filled Hard Capsules Market: https://www.globenewswire.com/news-release/2023/7/4/2699010/0/en/Liquid-Filled-Hard-Capsules-Market-to-Grow-at-a-CAGR-of-7-8-from-2022-to-2031-reaching-US-4-0-billion-As-per-TMR-Study.html
Oral Rehydration Solution [ORS] Market: https://www.globenewswire.com/news-release/2023/10/05/2755222/32656/en/Oral-Rehydration-Solution-ORS-Market-to-Exceed-USD-6-71-billion-by-2031-Capturing-a-9-9-CAGR-TMR-Report.html
Atopic Dermatitis Drugs Market: https://www.globenewswire.com/news-release/2023/07/31/2715115/32656/en/Atopic-Dermatitis-Drugs-Market-to-Grow-at-a-CAGR-of-14-7-from-2022-to-2031-reaching-USD-29-4-Billion-As-per-TMR-Study.html
Oligonucleotides Market: https://www.globenewswire.com/news-release/2024/12/02/2989923/32656/en/Oligonucleotides-Market-Outlook-2034-Projected-to-Reach-US-13-1-Billion-by-2034-Driven-by-Expanding-Applications-in-Biotechnology-and-Precision-Medicine-TMR.html
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact Us:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Radiopharmaceutical Theranostics Market Outlook 2031: From US$ 3.0 Billion in 2022 to Over US$ 12.4 Billion by 2031, Driven by Advances in Cancer Care and Precision Medicine here
News-ID: 4089420 • Views: …
More Releases from Transparency Market Research
Medium Voltage Fuse Market Outlook 2031: Global Market to Reach US$ 1.8 Billion …
The global medium voltage fuse market is steadily transitioning from a traditional grid-protection niche to a strategic enabler of modern power systems. Rising investments in renewable energy integration, large-scale electrification programs, and infrastructure upgrades are reshaping demand patterns worldwide. Medium voltage fuses-typically rated between 1 kV and 35 kV-are no longer viewed as passive safety components; instead, they are increasingly recognized as critical assets for grid stability, asset protection, and…
Lamination Films Market Outlook 2032: Global Industry Size to Surpass US$ 12.21 …
The global lamination films market was valued at US$ 8,123.4 million in 2023 and is forecast to reach US$ 8,514.1 million in 2024. Over the forecast period from 2024 to 2032, the market is projected to expand at a compound annual growth rate (CAGR) of 4.6%, ultimately exceeding US$ 12,213.1 million by 2032. This steady growth trajectory reflects the indispensable role of lamination films in modern packaging ecosystems across food,…
Global Curcumin Market Outlook 2031: Natural Antioxidant Demand, Regional Growth …
The global curcumin market is entering a structurally strong growth phase, underpinned by rising consumer preference for natural, plant-based ingredients and increasing clinical validation of curcumin's antioxidant and anti-inflammatory properties. As consumers shift away from synthetic additives and chemical-based therapeutics, curcumin is emerging as a high-value bioactive ingredient across , functional foods, cosmetics, and pharmaceuticals. Premiumization trends in organic products, combined with regulatory validation from food safety authorities, are expected…
Hemoglobin A1c Testing Devices Market to be Worth More Than USD 3.3 Bn by 2034 - …
The global Hemoglobin A1c (HbA1c) Testing Devices Market was valued at US$ 1.4 Bn in 2023 and is projected to expand at a CAGR of 7.7% from 2024 to 2034, reaching more than US$ 3.3 Bn by the end of 2034. The market growth is primarily attributed to the increasing global burden of diabetes, growing awareness about disease management, and technological advancements in diagnostic devices.
Get a concise overview of key…
More Releases for Theranostics
Key Factor Supporting Global Theranostics Market Development in 2025: Rising Can …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Theranostics Market Size By 2025?
The overall scale of the theranostics sector has experienced swift expansion lately, charting an increase from a valuation of $111.1 billion in 2024 to an anticipated $122.98 billion by 2025, reflecting a compound annual growth rate (CAGR) of 10.7%; this…
Theranostics Market in 2025 Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Theranostics Market -(Product (Diagnostic imaging, Radiopharmaceuticals, Biomarker screening and Software), Application (Prostate Cancer, Bone Metastasis, Other Cancers, Other Application), End-user (Hospitals & Cancer Care Centers, Theranostics Centers, and Research & Academic Centers)) Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Theranostics Market Size is valued…
Rising Cancer Prevalence Fuels Growth In The Theranostics Market Driver: Leading …
What combination of drivers is leading to accelerated growth in the theranostics market?
The theranostics market is forecasted to grow due to an upward trend in cancer cases. Cancer, a disease characterized by unchecked cell growth affecting numerous organs, is a leading cause of considerable illness and death globally. Theranostics, combining therapeutic and diagnostic aspects, holds significant prospects in managing cancer and chronic illnesses. This methodology paves the way for tailored…
Theranostics Market worth $4.3 billion by 2028
The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall theranostics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies.
Theranostics Market [https://www.marketsandmarkets.com/Market-Reports/theranostics-market-111696976.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] in terms of revenue was estimated to be worth $2.1 billion in 2023 and is poised to reach $4.3…
Theranostics Market: Pioneering Precision Medicine into 2030
The Theranostics Market was valued USD 1.9 Billion in 2023 and projected to reach USD 5.4 Billion by 2030, growing at a CAGR of 16.2% during the forecast period of 2024-2030.
The Theranostics Market report studies the competitive environment of the Theranostics Market based on company profiles and their efforts to increase product value and production. The Theranostics Market report discusses various factors driving or restraining the market, which will help…
Theranostics Market Is Booming Worldwide Just Published
Global Theranostics Market: An Overview
Theranostics is a new field of medicine which relies on targeted therapies to conduct specific targeted tests. These tests are mainly used for various forms of cancers. The key concern in the therapeutics involve patient centric care with the help of more personalised and precise approach. The technique relies on the use of diagnostic and therapeutic applications to form a single agent. The system is known…
